Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for the Treatment of SLE
NCT00779194Phase 2Completed
- Sponsor
- Upstate Medical University
- Start
- Oct 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in systemic lupus erythematosus (SLE), sponsored by Upstate Medical University. Started Oct 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00779194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00779194.